Gilead Sciences (GILD)
(Delayed Data from NSDQ)
$65.96 USD
+1.38 (2.14%)
Updated May 10, 2024 04:00 PM ET
After-Market: $65.92 -0.04 (-0.06%) 7:58 PM ET
4-Sell of 5 4
B Value C Growth F Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: -- |
6/2024 | $1.58 | 0.00% |
Earnings Summary
For their last quarter, Gilead Sciences (GILD) reported earnings of -$1.32 per share, beating the Zacks Consensus Estimate of $-1.49 per share. This reflects a positive earnings surprise of 11.41%. Look out for GILD's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of $1.58 per share, reflecting a year-over-year increase of 17.91%.
Earnings History
Price & Consensus
Zacks News for GILD
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?
GILD: What are Zacks experts saying now?
Zacks Private Portfolio Services